5American Thoracic Society. Dyspnoea: mechanisms, assessment and management: a consensus statement[J]. Am J Respir Crit Care Med, 1999,159: 321 - 340
6Jennings AL, Davies AN, Higgins JPT, et al. Opioids for the palliation of breathlessness in terminal illness[J]. Cochrane Dattabase Syst Rev, 2002,4:1 - 33
7Jennings AL, Davies AN, Higgins JPT, et al. A systematic review of the use of pioids in the management of dyspnoea[J] .Thorax,2002,57:939 - 944
8Polosa R,Simidchiev A, Walters EH.Nebulised morphine for severe interstitial lung disease[J] .The Cochrane Database Syst Rev,2004,1
9Varkey, Basil MDFCCP. Palliative care for end-stage lung disease patients [J]. Clinical Pulmonary Medicine, 2003,10(5) :269 - 277
10Cohen MH, Anderson AJ, Krasnow SH, et al. Continunous intravenous infusion of morphine for severe dyspnea[J] .South Med J, 1991,84:229 - 234
3Levy M H, Back A, Bazargan S, et al. Palliative Care. National Comprehensive Cancer Network . Clinical practice guidelines in ontology [J]. J Nail Compr Cane Netw, 2006,4(8): 776-818.
4Bonnichon A, Le Floch H, Riviere F, et al. Dyspnea in lung cancer [J]. Rev Pneumol Clini, 2008, 64(2) : 62-68.
5Mazzocato C, Buclin T, Rapin C H. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized doubleblind controlled trial [J]. Ann Oncol, 1999, 10 (12): 1511-1514.
6Navigante A H, Cerchiietti L C, Castro M A, et al. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer [J]. Pain Symptom Manage, 2006,31(1):38-47.
7Cohen M H, Anderson A J, Krasnow S H, et al. Continuous intravenous infusion of morphine for severe dyspnea [J]. South Med J, 1991,84(2): 229-234.
8Boyd K J, Kelly M. Oral morphine as symptomatic treatment of dyspnea in patients with advanced cancer [J]. Palliat Med, 1997, 11(4): 277-281.
9Susan B L, Elias A K, Declan W, et al. Opioids, respiratory function, and dyspnea. [J]. Am J Hosp Palliat Care, 2003, 20(1): 57-61.
10Charles M A, Reymond L, Israel F. Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline [J]. J Pain Symptom Manag, 2008, 36(1):29-38.
